- 0人关注
g&c iv hong kong limited
股票筛选 · · · · · ·
| g&c iv hong kong limited十大流通股股票 | g&c iv hong kong limited十大股东股票 |
| 序号 | 股票 | 持股数量(万股) | 股价 | 至今涨幅 | 股份性质 | 占总股本比例 | 持股变动 | 总市值 | 报告期 |
| 1 | 药明康德603259历史分时日K | 10462.61 | 52.36 | 境外法人股 | 3.593% | 未变 | 2024-09-30 | ||
| 2 | 药明康德603259历史分时日K | 10462.61 | 境外法人股 | 3.593% | 未变 | 2024-09-10 | |||
| 3 | 药明康德603259历史分时日K | 10462.61 | 39.19 | 境外法人股 | 3.593% | 未变 | 2024-06-30 | ||
| 4 | 药明康德603259历史分时日K | 10462.61 | 46.18 | 境外法人股 | 3.567% | 未变 | 2024-03-31 | ||
| 5 | 药明康德603259历史分时日K | 10462.61 | 境外法人股 | 3.543% | 减持 | 2024-03-08 | |||
| 6 | 药明康德603259历史分时日K | 10500 | 流通A股 | 3.54% | 增持 | 2024-02-01 | |||
| 7 | 药明康德603259历史分时日K | 10462.61 | 72.76 | 境外法人股 | 3.524% | 未变 | 2023-12-31 | ||
| 8 | 药明康德603259历史分时日K | 10462.61 | 86.18 | 境外法人股 | 3.525% | 减持 | 2023-09-30 | ||
| 9 | 药明康德603259历史分时日K | 11187.33 | 62.31 | 境外法人股 | 3.776% | 减持 | 2023-06-30 | ||
| 10 | 药明康德603259历史分时日K | 11830.71 | 79.50 | 境外法人股 | 3.995% | 减持 | 2023-03-31 | ||
| 11 | 药明康德603259历史分时日K | 12922.43 | 81.00 | 境外法人股 | 4.375% | 减持 | 2022-12-31 | ||
| 12 | 药明康德603259历史分时日K | 13391.91 | 71.69 | 境外法人股 | 4.534% | 减持 | 2022-09-30 | ||
| 13 | 药明康德603259历史分时日K | 13931.93 | 103.99 | 境外法人股 | 4.732% | 未变 | 2022-06-30 | ||
| 14 | 药明康德603259历史分时日K | 13931.93 | 112.38 | 境外法人股 | 4.74% | 未变 | 2022-03-31 | ||
| 15 | 药明康德603259历史分时日K | 13931.93 | 118.58 | 境外法人股 | 4.74% | 未变 | 2021-12-31 | ||
| 16 | 药明康德603259历史分时日K | 13931.93 | 152.80 | 境外法人股 | 4.745% | 未变 | 2021-09-30 | ||
| 17 | 药明康德603259历史分时日K | 13931.93 | 156.59 | 境外法人股 | 4.766% | 新进 | 2021-06-30 |
| 序号 | 股票 | 持股数量(万股) | 股价 | 至今涨幅 | 股份性质 | 占总股本比例 | 持股变动 | 总市值 | 报告期 |
| 1 | 药明康德603259历史分时日K | 10462.61 | 52.36 | 流通A股 | 3.59% | 未变 | 2024-09-30 | ||
| 2 | 药明康德603259历史分时日K | 10462.61 | 流通A股 | 3.59% | 未变 | 2024-09-10 | |||
| 3 | 药明康德603259历史分时日K | 10462.61 | 39.19 | 流通A股 | 3.59% | 未变 | 2024-06-30 | ||
| 4 | 药明康德603259历史分时日K | 10462.61 | 46.18 | 流通A股 | 3.57% | 未变 | 2024-03-31 | ||
| 5 | 药明康德603259历史分时日K | 10462.61 | 流通A股 | 3.54% | 减持 | 2024-03-08 | |||
| 6 | 药明康德603259历史分时日K | 10500 | 流通A股 | 3.54% | 增持 | 2024-02-01 | |||
| 7 | 药明康德603259历史分时日K | 10462.61 | 72.76 | 流通A股 | 3.52% | 未变 | 2023-12-31 | ||
| 8 | 药明康德603259历史分时日K | 10462.61 | 86.18 | 流通A股 | 3.52% | 减持 | 2023-09-30 | ||
| 9 | 药明康德603259历史分时日K | 11187.33 | 62.31 | 流通A股 | 3.77% | 减持 | 2023-06-30 | ||
| 10 | 药明康德603259历史分时日K | 11830.71 | 79.50 | 流通A股 | 3.99% | 减持 | 2023-03-31 | ||
| 11 | 药明康德603259历史分时日K | 12922.43 | 81.00 | 流通A股 | 4.36% | 减持 | 2022-12-31 | ||
| 12 | 药明康德603259历史分时日K | 13391.91 | 71.69 | 流通A股 | 4.52% | 减持 | 2022-09-30 | ||
| 13 | 药明康德603259历史分时日K | 13931.93 | 103.99 | 4.71% | 未变 | 2022-06-30 | |||
| 14 | 药明康德603259历史分时日K | 13931.93 | 112.38 | 流通A股 | 4.71% | 未变 | 2022-03-31 | ||
| 15 | 药明康德603259历史分时日K | 13931.93 | 118.58 | 流通A股 | 4.71% | 未变 | 2021-12-31 | ||
| 16 | 药明康德603259历史分时日K | 13931.93 | 152.80 | 流通A股 | 4.72% | 未变 | 2021-09-30 | ||
| 17 | 药明康德603259历史分时日K | 13931.93 | 156.59 | 4.72% | 增持 | 2021-06-30 | |||
| 18 | 药明康德603259历史分时日K | 11609.94 | 116.53 | 限售流通A股 | 4.74% | 未变 | 2021-03-31 | ||
| 19 | 药明康德603259历史分时日K | 11609.94 | 4.75% | 未变 | 2020-12-31 | ||||
| 20 | 药明康德603259历史分时日K | 11609.94 | 限售流通股 | 4.75% | 未变 | 2020-09-30 | |||
| 21 | 药明康德603259历史分时日K | 11609.94 | 4.75% | 未变 | 2020-09-23 | ||||
| 22 | 药明康德603259历史分时日K | 11609.94 | 限售流通股 | 0% | 未变 | 2020-08-31 | |||
| 23 | 药明康德603259历史分时日K | 11609.94 | 5.02% | 增持 | 2020-06-30 | ||||
| 24 | 药明康德603259历史分时日K | 8292.82 | 5.02% | 未变 | 2020-03-31 | ||||
| 25 | 药明康德603259历史分时日K | 8292.82 | 5.02% | 未变 | 2019-12-31 | ||||
| 26 | 药明康德603259历史分时日K | 8292.82 | 5.06% | 增持 | 2019-09-30 | ||||
| 27 | 药明康德603259历史分时日K | 5923.44 | 5.06% | 未变 | 2019-06-30 | ||||
| 28 | 药明康德603259历史分时日K | 5923.44 | 限售流通股 | 5.06% | 未变 | 2019-03-31 | |||
| 29 | 药明康德603259历史分时日K | 5923.44 | 限售流通股 | 5.09% | 未变 | 2018-12-31 | |||
| 30 | 药明康德603259历史分时日K | 5923.44 | 流通受限股份 | 5.68% | 未变 | 2018-09-30 | |||
| 31 | 药明康德603259历史分时日K | 5923.44 | 流通受限股份 | 5.68% | 未变 | 2018-06-30 | |||
| 32 | 药明康德603259历史分时日K | 5923.44 | 流通受限股份 | 5.685% | 未变 | 2018-05-07 | |||
| 33 | 药明康德603259历史分时日K | 5923.44 | 限售流通股 | 0% | 新进 | 2018-04-24 |
g&c iv hong kong limited解禁股票 · · · · · ·
| 股票 | 解禁数量(万股) | 限售股类型 | 其他承诺描述 | 解禁日期 |
| 药明康德603259历史分时日K | 11609.9 | 首发原股东持股 | 2021-05-10 | |
| 药明康德603259历史分时日K | 5923.44 | 首发原股东持股 | 2021-05-08 |
更多+++
热搜牛散
热门股票